scholarly journals Double Chromosomal Anomalies in Turner Syndrome: Rare Co-existence of Robertsonian Translocation with Monosomy X and Isochromosome XQ

2021 ◽  
Vol 9 (3) ◽  
pp. 421-423
Author(s):  
Prachi Sinkar ◽  
Sandhya Iyer
2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Carolyn Bondy

The past decade produced important advances in molecular genetic techniques potentially supplanting the traditional cytogenetic diagnosis of Turner syndrome (TS). Rapidly evolving genomic technology is used to screen 1st trimester pregnancies for sex chromosomal anomalies including TS, and genomic approaches are suggested for the postnatal diagnosis of TS. Understanding the interpretation and limitations of new molecular tests is essential for clinicians to provide effective counseling to parents or patients impacted by these tests. Recent studies have advanced the concept that X chromosome genomic imprinting influences expression of the Turner phenotype and contributes to gender differences in brain size and coronary disease. Progress in cardiovascular MRI over the past decade has dramatically changed our view of the scope and criticality of congenital heart disease in TS. Cardiac MRI is far more effective than transthoracic echocardiography in detecting aortic valve abnormalities, descending aortic aneurysm, and partial anomalous pulmonary venous return; recent technical advances allow adequate imaging in girls as young as seven without breath holding or sedation. Finally, important developments in the area of gynecological management of girls and young women with TS are reviewed, including prognostic factors that predict spontaneous puberty and potential fertility and recent practice guidelines aimed at reducing cardiovascular risk for oocyte donation pregnancies in TS.


Author(s):  
Yalda Afshar ◽  
Lawrence D. Platt
Keyword(s):  

2019 ◽  
Vol 65 (3) ◽  
pp. 231-237 ◽  
Author(s):  
Kazuhiro UMEYAMA ◽  
Kazuaki NAKANO ◽  
Hitomi MATSUNARI ◽  
Takeshi YAMADA ◽  
Koki HASEGAWA ◽  
...  

Author(s):  
Evren GUMUS

In the present paper, we report two rare cases of Down syndrome (DS); mosaic Down-Turner syndrome and DS with rob (13;14). Patient 1 karyotype is mos 45,X[41] / 47, XX,+21[59] and patient 2 karyotype is 46, XY, rob (13;14)(q10;q10),+21. With these two unusual cases, we aimed to look at the most common numerical and structural chromosome anomalies from a different window and evaluate the phenotypic effect in the presence of different chromosomal anomalies. Our main goal is to evaluate the phenotypic characteristics of these two rare variants in the light of literature.


Author(s):  
V.V. Ezhova, T.M. Vdovina

Objective. The frequency of monosomy X is estimated. The diagnostic value of various ultrasound markers in a fetus with Turner syndrome in the first and second trimesters of pregnancy was evaluated. Materials. The database of cytogenetic studies from 2008 to 2018 of our center was analysed. Studies include invasive prenatal diagnosis and research on abortion material. Two clinical observations of Turner's syndrome identified in the second trimester of pregnancy were considered. Results. Of 3450 cytogenetic studies, 70 karyotypes of monosomy X were detected, the full form was found in 57 (81 %) cases, mosaic — 13 (19 %). The 46 karyotypes of monosomy X were non-developing pregnancies and 24 cases of invasive prenatal diagnosis. In the group of non-developing pregnancies, the complete form of monosomy X was observed in 40 (86.9 %) cases, mosaic — in 6 (13.1 %), embryo death in 73 % of cases occurred in the period of 8–9 weeks of gestation. The data of two clinical observations of Turner syndrome identified in the second trimester are presented. The finding ultrasonic markers of monosomy X in the analysed studies are considered. Conclusion. The detection of monosomy X is possible in most cases in the first trimester. However, the variability of symptoms and their severity does not always allow identify this pathology in the early stages. The search for soft markers during the second trimester ultrasound, the widespread use of echocardiography and a comprehensive assessment of all the studies performed can increase the frequency of detection of Turner syndrome.


2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A733-A734
Author(s):  
Priyanka Ghosh ◽  
Zorkot Zeinab ◽  
Selma Feldman Witchel ◽  
Meredith Snook ◽  
Svetlana Yatsenko

Abstract Background Turner Syndrome (TS) is the most common chromosomal abnormality seen in females and is often diagnosed in childhood. The transition of patients with TS from pediatric to adult providers is characterized by inconsistency. As such, limited data are available to assess long term health outcomes of women with TS. Objectives: 1) To evaluate the long term health outcomes in women with TS followed at a single academic institution and 2) to establish clinical recommendations for evaluation, counseling, and planned transition of this population. Methods: A retrospective pilot study was performed by examining medical records of women with TS who presented with short stature or delayed puberty and were diagnosed with TS on the basis of cytogenetic analysis. Patients with monosomy X, mosaic monosomy X, or X chromosome structural abnormalities consistent with TS or mosaic TS diagnosis were included. Medical records from an academic children’s hospital and an affiliated women’s hospital were reviewed. Results: To date, 15 females aged 26-32 years were identified. Electronic records were available for 12/15 with age at diagnosis ranging from in utero to 15 years of age. Those with pediatric information available had documentation addressing use of growth hormone and pubertal hormone replacement therapies. Of the 12 patients, 11 had cardiac imaging performed; only one had an MRI. Consistent planned transition to adult health care providers was not evident. Of the 12 patients, 3 had consultation with a Reproductive Endocrinology and Infertility specialist; 3 had a diagnosis of anxiety or depression; 3 had a DEXA scan done (1 had osteopenia); 5 had dyslipidemia; and 2 developed insulin resistance. Conclusions: This pilot study confirms heterogeneity in practice patterns and variable interactions of women with TS with the healthcare system, especially as patients enter adulthood. Although some women were referred to subspecialists, our initial data uncover patient uncertainty about healthcare and transition recommendations. Our preliminary data indicate the need for early patient education in a collaborative, multi-disciplinary fashion. We plan to validate and extend our initial findings by reviewing additional medical records. Ultimately, we plan for expanded education, consistent surveillance recommendations, and planned transition of patients with TS from pediatrics to adult caregivers.


2017 ◽  
Vol 88 (3-4) ◽  
pp. 291-297 ◽  
Author(s):  
Tamar G. Baer ◽  
Christopher E. Freeman ◽  
Claudia Cujar ◽  
Mahesh Mansukhani ◽  
Bahadur  Singh ◽  
...  

Although monosomy X is the most common karyotype in patients with Turner syndrome, the presence of Y chromosome material has been observed in about 10% of patients. Y chromosome material in patients with Turner syndrome poses an increased risk of gonadoblastoma and malignant transformation. We report a woman with a diagnosis of Turner syndrome at 12 years of age, without signs of virilization, and karyotype reported as 46,X,del(X)(q13). At 26 years, cytogenetic studies indicated the patient to be mosaic for monosomy X and a cell line that contained a du­plicated Yq chromosome. Bilateral gonadectomy was performed and revealed streak gonads, without evidence of gonadoblastoma. Histological analysis showed ovarian stromal cells with few primordial tubal structures. FISH performed on streak gonadal tissue showed a heterogeneous distribution of SRY, with exclusive localization to the primordial tubal structures. DNA extraction from the gonadal tissue showed a 6.5% prevalence of SRY by microarray analysis, contrasting the 86% prevalence in the peripheral blood sample. This indicates that the overall gonadal sex appears to be determined by the majority gonosome complement in gonadal tissue in cases of sex chromosome mosaicism. This case also raises questions regarding malignancy risk associated with Y prevalence and tubal structures in gonadal tissue.


2003 ◽  
Vol 23 (9) ◽  
pp. 769-770 ◽  
Author(s):  
S�rgio D. J. Pena ◽  
Rosane Sturzeneker

2006 ◽  
Vol 29 (1) ◽  
pp. 47-48 ◽  
Author(s):  
Aline Lourenço da Silva ◽  
Renata LL Ferreira de Lima ◽  
Lucilene Arilho Ribeiro ◽  
Danilo Moretti-Ferreira

Sign in / Sign up

Export Citation Format

Share Document